Colorectal cancer screening: A comparison of 35 initiatives in 17 countries

被引:202
作者
Benson, Victoria S. [2 ]
Patnick, Julietta [2 ,3 ]
Davies, Anna K. [4 ]
Nadel, Marion R. [5 ]
Smith, Robert A. [6 ]
Atkin, Wendy S. [1 ]
机构
[1] NW London Hosp Trust, St Marks Hosp, Canc Res UK Colorectal Canc Unit, Harrow HA1 3UJ, Middx, England
[2] Univ Oxford, Canc Epidemiol Unit, Oxford OX1 2JD, England
[3] NHS Canc Screening Programmes, Sheffield, S Yorkshire, England
[4] UCL, Dept Clin Hlth Psychol, London WC1E 6BT, England
[5] Ctr Dis Control & Prevent, Div Canc Prevent & Control, Atlanta, GA USA
[6] Amer Canc Soc, Canc Control Dept, Atlanta, GA 30329 USA
关键词
colonoscopy; colorectal cancer screening; fecal occult blood test; flexible sigmoidoscopy; geographic variation;
D O I
10.1002/ijc.23273
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Although in its infancy, organized screening for colorectal cancer (CRC) in the general population is increasing at regional and national levels. Documenting and describing these initiatives is critical to identifying, sharing and promoting best practice in the delivery of CRC screening. Subsequently, the International Colorectal Cancer Screening Network (ICRCSN) was established in 2003 to promote best practice in the delivery of organized screening programs. The initial aim was to identify and document organized screening initiatives that commenced before May 2004. Each identified initiative was sent 1 questionnaire per screening modality: fecal occult blood test, flexible sigmoidoscopy or total colonoscopy. Information was collected on screening methodology, testing details and initiative status. In total, 35 organized initiatives were identified in 17 countries, including 10 routine population-based screening programs, 9 pilots and 16 research projects. Fecal occult blood tests were the most frequently used screening modality, and total colonoscopy was seldom used as a primary screening test. The eligible age for screening ranged from 40 years old to no upper limit; most initiatives included participants aged 50 to 64. Recruitment was usually done by a mailed invitation or during a visit to a family physician. In conclusion, this is the first investigation describing the delivery of CRC screening protocols to various populations. The work of the ICRCSN is enabling valuable information to be shared and a common nomenclature to be established. (C) 2007 Wiley-Liss, Inc.
引用
收藏
页码:1357 / 1367
页数:11
相关论文
共 20 条
  • [1] *ADV COMM CANC PRE, 1999, EUR J CANCER, V36, P1473
  • [2] Single flexible sigmoidoscopy screening to prevent colorectal cancer: baseline findings of a UK multicentre randomised trial
    Atkin, WS
    Cook, CF
    Cuzick, J
    Edwards, R
    Northover, JMA
    Wardle, J
    [J]. LANCET, 2002, 359 (9314) : 1291 - 1300
  • [3] The Norwegian Colorectal Cancer Prevention (NORCCAP) screening study
    Gondal, G
    Grotmol, T
    Hofstad, B
    Bretthauer, M
    Eide, TJ
    Hoff, G
    [J]. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2003, 38 (06) : 635 - 642
  • [4] Randomised controlled trial of faecal-occult-blood screening for colorectal cancer
    Hardcastle, JD
    Chamberlain, JO
    Robinson, MHE
    Moss, SM
    Amar, SS
    Balfour, TW
    James, PD
    Mangham, CM
    [J]. LANCET, 1996, 348 (9040) : 1472 - 1477
  • [5] International Agency for Research on Cancer, 2002, IARC HDB CANC PREV, P47
  • [6] A randomised study of screening for colorectal cancer using faecal occult blood testing: results after 13 years and seven biennial screening rounds
    Jorgensen, OD
    Kronborg, O
    Fenger, C
    [J]. GUT, 2002, 50 (01) : 29 - 32
  • [7] Randomised study of screening for colorectal cancer with faecal-occult-blood test
    Kronborg, O
    Fenger, C
    Olsen, J
    Jorgensen, OD
    Sondergaard, O
    [J]. LANCET, 1996, 348 (9040) : 1467 - 1471
  • [8] The Global Challenge of Colorectal Cancer. Reports from the UICC International Workshop on Facilitating Screening for Colorectal Cancer: An International Agenda
    Levin, B
    Smith, RA
    [J]. ANNALS OF ONCOLOGY, 2005, 16 (01) : 23 - 23
  • [9] The effect of fecal occult-blood screening on the incidence of colorectal cancer
    Mandel, JS
    Church, TR
    Bond, JH
    Ederer, F
    Geisser, MS
    Mongin, SJ
    Snover, DC
    Schuman, LM
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (22) : 1603 - 1607
  • [10] REDUCING MORTALITY FROM COLORECTAL-CANCER BY SCREENING FOR FECAL OCCULT BLOOD
    MANDEL, JS
    BOND, JH
    CHURCH, TR
    SNOVER, DC
    BRADLEY, GM
    SCHUMAN, LM
    EDERER, F
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1993, 328 (19) : 1365 - 1371